A detailed history of Nuveen Asset Management, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 118,486 shares of NKTX stock, worth $280,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,486
Previous 272,396 56.5%
Holding current value
$280,811
Previous $1.61 Million 66.75%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.52 - $8.0 $695,673 - $1.23 Million
-153,910 Reduced 56.5%
118,486 $535,000
Q2 2024

Aug 09, 2024

BUY
$5.27 - $10.82 $207,142 - $425,290
39,306 Added 16.86%
272,396 $1.61 Million
Q1 2024

May 13, 2024

BUY
$5.59 - $15.71 $789,095 - $2.22 Million
141,162 Added 153.56%
233,090 $2.52 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $13,800 - $69,531
10,535 Added 12.94%
91,928 $606,000
Q3 2023

Nov 14, 2023

SELL
$1.39 - $2.29 $562,255 - $926,305
-404,500 Reduced 83.25%
81,393 $113,000
Q2 2023

Aug 14, 2023

SELL
$2.19 - $5.17 $5,321 - $12,563
-2,430 Reduced 0.5%
485,893 $1.06 Million
Q1 2023

May 15, 2023

SELL
$3.37 - $6.3 $922,342 - $1.72 Million
-273,692 Reduced 35.92%
488,323 $1.73 Million
Q4 2022

Feb 14, 2023

BUY
$5.14 - $14.35 $367,998 - $1.03 Million
71,595 Added 10.37%
762,015 $4.56 Million
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $4.17 Million - $6.25 Million
339,858 Added 96.95%
690,420 $9.09 Million
Q2 2022

Aug 15, 2022

BUY
$7.77 - $19.44 $2.27 Million - $5.67 Million
291,734 Added 495.91%
350,562 $4.32 Million
Q1 2022

May 16, 2022

BUY
$8.66 - $14.99 $4,849 - $8,394
560 Added 0.96%
58,828 $679,000
Q4 2021

Feb 14, 2022

SELL
$12.79 - $26.88 $53,679 - $112,815
-4,197 Reduced 6.72%
58,268 $772,000
Q3 2021

Nov 12, 2021

SELL
$26.67 - $38.76 $531,799 - $772,874
-19,940 Reduced 24.2%
62,465 $1.96 Million
Q2 2021

Aug 16, 2021

SELL
$23.94 - $36.68 $245,289 - $375,823
-10,246 Reduced 11.06%
82,405 $2.61 Million
Q1 2021

May 17, 2021

BUY
$31.33 - $59.61 $738,354 - $1.4 Million
23,567 Added 34.11%
92,651 $3.05 Million
Q4 2020

Feb 16, 2021

BUY
$27.03 - $75.62 $151,719 - $424,455
5,613 Added 8.84%
69,084 $4.25 Million
Q3 2020

Nov 16, 2020

BUY
$23.52 - $47.9 $1.49 Million - $3.04 Million
63,471 New
63,471 $1.91 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $115M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.